OBJECTIVE: The purpose of our study was to report the multiphasic CT findings in patients with symptomatic liver involvement by hereditary hemorrhagic telangiectasia (HHT) and to correlate the CT findings with the type of clinical presentation. CONCLUSION: Patients with symptomatic HHT liver disease have diffuse hepatic telangiectases, a dilated common hepatic artery, and a high incidence of biliary abnormalities. Multiphasic CT is useful in diagnosing liver involvement due to HHT; however, no strong correlation was seen between CT findings and the clinical subtype of HHT liver disease.
OBJECTIVE: The purpose of our study was to report the multiphasic CT findings in patients with symptomatic liver involvement by hereditary hemorrhagic telangiectasia (HHT) and to correlate the CT findings with the type of clinical presentation. CONCLUSION:Patients with symptomatic HHT liver disease have diffuse hepatic telangiectases, a dilated common hepatic artery, and a high incidence of biliary abnormalities. Multiphasic CT is useful in diagnosing liver involvement due to HHT; however, no strong correlation was seen between CT findings and the clinical subtype of HHT liver disease.
Authors: A Scardapane; A Stabile Ianora; C Sabbà; M Moschetta; P Suppressa; L Castorani; G Angelelli Journal: Radiol Med Date: 2011-06-04 Impact factor: 3.469
Authors: Marcello Candelli; Maurizio Pompili; Patrizia Suppressa; Gennaro M Lenato; Giulia Bosco; Gian Ludovico Rapaccini; Antonio Gasbarrini; Arnaldo Scardapane; Carlo Sabbà Journal: Intern Emerg Med Date: 2011-02-09 Impact factor: 3.397
Authors: A Scardapane; M Ficco; C Sabbà; F Lorusso; M Moschetta; N Maggialetti; P Suppressa; G Angelelli; A A Stabile Ianora Journal: Radiol Med Date: 2012-02-10 Impact factor: 3.469
Authors: Angela E Lin; Craig T Basson; Elizabeth Goldmuntz; Pilar L Magoulas; Deborah A McDermott; Donna M McDonald-McGinn; Elspeth McPherson; Colleen A Morris; Jacqueline Noonan; Catherine Nowak; Mary Ella Pierpont; Reed E Pyeritz; Alan F Rope; Elaine Zackai; Barbara R Pober Journal: Genet Med Date: 2008-07 Impact factor: 8.822